Beacon Capital Management »

Peregrine Pharmaceuticals shares owned by Beacon Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Beacon Capital Management from 13F filings

Historical chart of Beacon Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Beacon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Beacon Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $839 68 12.35
2024-09-30 $774 68 11.38
2024-06-30 $486 68 7.15
2024-03-31 $456 68 6.71

More positions owned by Beacon Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr Ultra Short Govt (BILZ)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Growth Etf (VUG)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard World Inf Tech Etf (VGT)
Apple (AAPL)
Simplify Exchange Traded Fun Managed Futures (CTA)
NVIDIA Corporation (NVDA)
Simplify Exchange Traded Fun Treasury Opt Inc (BUCK)
Simplify Exchange Traded Fun Volatility Prem (SVOL)

View all positions for Beacon Capital Management

Top funds holding Peregrine Pharmaceuticals

BlackRock
AltraVue Capital
Vanguard Group
Glazer Capital
Punch & Associates Investment Management
State Street Corporation
Fil
Royal Bank of Canada
Goldman Sachs Group
Alpine Associates Management
Highland Capital Management Fund Advisors
Water Island Capital
CNH Partners
Hsbc Holdings
Geode Capital Management

View all funds holding Peregrine Pharmaceuticals